Conjunct action of gamma radiation and casiopeinas in two cellular types

In Mexico the cancer occupies the second place in the causes of death and although already there are diverse useful treatments to attack this suffering, the search of new pharmaceuticals that present positive effect in the treatment of the cancer there is taken to the development of a group of substances called Casiopeinas. Its are coordination compounds constituted by a central atom of copper (Cu II) joined to organic ligands, with general condensed formula [Cu (NN)(ON)]NO3, or [Cu(NN)(OO)]NO3. Its present different cytotoxicity levels, as well as in vitro antineoplastic activity in diverse tissues derived of tumors. Even its ignore the mechanisms of it action, but one of them, it could be by generation of reactive species of oxygen (ERO), mediated by the metallic center that contain. Thinking of this possibility was carried out in vitro experiments, exposing lymphocytes or HeLa cells, to ionizing radiation, at two casiopeinas (Casiopeina llgly and the Casiopeina Ill-e-a) or the combination of both agents, in order to determine if the antineoplastic capacity of both types of treatments increase in conjunct action. To determine it its were carried out cytotoxicity tests by means of the differential dyeing of fluorescein diacetate and etidio bromide, in these the cells alive fluorescein in green color while the dead ones only the nucleus of red tinged. The genotoxicity was evaluated by means of the comet essay. The results hurtled that as much the casiopeinas as the radiation by separate don't present difference among both cellular types, probably due to the used method that only quantifies the damages at the moment and not to long term. And according to those treatments on the whole only to the concentrations and the doses more high it favors the additive effect due to an overproduction of free radicals that not can be neutralized. According to the genotoxicity, only proven for the radiation indicates that the HeLa cells presents a major number of cells with damages in comparison of the lymphocytes. (Author)